₹1,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 5 Years
If you had started a ₹1,000/month SIP on 1 Oct 2021 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 61 installments.
You invested
₹61,000
61 installments
Value today
₹89,542
1 Oct 2026
Absolute gain
+₹28,542
+46.8%
XIRR (annualised)
15.57%
money-weighted
The journey, month by month
Worst fall on the way
-13.4%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹71,558
Modelled at historical FD rates. The fund beat FD by ₹17,984.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (3 Oct 2022) | ₹13,000 | ₹12,960 | -0.3% |
| Year 2 (3 Oct 2023) | ₹25,000 | ₹30,100 | +20.4% |
| Year 3 (1 Oct 2024) | ₹37,000 | ₹59,354 | +60.4% |
| Year 4 (1 Oct 2025) | ₹49,000 | ₹68,982 | +40.8% |
| Year 5 (1 Oct 2026) | ₹61,000 | ₹89,542 | +46.8% |
Best year of the journey: Year 3 (+41% market move) · Toughest year: Year 4 (-3.3%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 1 Oct 2021 and 1 Oct 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.